PHACE Syndrome with Large Facial Segmental Hemangioma and Cerebellar Hypoplasia
10.15264/cpho.2017.24.2.140
- Author:
Young Joon LEE
1
;
Gyu Min YEON
;
Seom Gim KONG
Author Information
1. Department of Pediatrics, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea. ana313@hanmail.net
- Publication Type:Case Report
- Keywords:
PHACE association;
Propranolol;
Cerebellar hypoplasia;
Hemangioma
- MeSH:
Anterior Cerebral Artery;
Hemangioma;
Humans;
Infant;
Propranolol;
Stroke
- From:Clinical Pediatric Hematology-Oncology
2017;24(2):140-143
- CountryRepublic of Korea
- Language:English
-
Abstract:
Infantile hemangiomas are the most common benign tumors in infants. Facial segmental hemangiomas are often accompanied by other anomalies, and pre-treatment evaluation is needed. PHACE syndrome is associated with Posterior fossa anomalies, Hemangiomas, Arterial anomalies, Cardiac anomalies, and Eye anomalies (PHACE). PHACE syndrome is diagnosed in about 30% of patients with facial segmental hemangiomas. In PHACE syndrome, facial hemangioma usually requires initial treatment; propranolol use is increasing as a first-line treatment despite the risk of stroke. We report a case of PHACE syndrome in a patient with large facial hemangiomas, left cerebellar hypoplasia, and an absent A1 segment of the anterior cerebral artery. After 1 year of treatment with oral propranolol, facial hemangiomas improved and normal development was observed until 24 months of age. Evaluation of PHACE syndrome is important in patients with large facial segmental hemangiomas, and propranolol can be considered a first-line therapy for hemangioma.
